Tenascin C in metastasis: A view from the invasive front
Open accessThe DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.
Abstract
The extracellular matrix protein tenascin C (TNC) is a large glycoprotein expressed in connective tissues and stem cell niches. TNC over-expression is repeatedly observed in cancer, often at the invasive tumor front, and is associated with poor clinical outcome in several malignancies. The link between TNC expression and poor survival in cancer patients suggests a role for TNC in metastatic progression, which is responsible for the majority of cancer related deaths. Indeed, functional studies using mouse models are revealing new roles of TNC in cancer progression and underscore its important contribution to the development of metastasis. TNC has a pleiotropic role in advancing metastasis by promoting migratory and invasive cell behavior, angiogenesis and cancer cell viability under stress. TNC is an essential component of the metastatic niche and modulates stem cell signaling within the niche. This may be crucial for the fitness of disseminated cancer cells confronted with a foreign environment in secondary organs, that can exert a strong selective pressure on invading cells. TNC is a compelling example of how an extracellular matrix protein can provide a molecular context that is imperative to cancer cell fitness in metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It also derive proliferation, angiogenesis and metastasis stages of tumor progression [134].”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
A Perspective on Cancer Cell Metastasis
Chaffer, C. L., & Weinberg, R. A. (2011) · Science · doi:10.1126/science.1203543 · Cited by 4,807
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684 · cited 2×
“These steps in metastatic progression are driven by genetic and epigenetic alterations in cancer cells, but also require supportive signals from the surrounding microenvironment.(2,3) The tumor microenvironment, comprised of cellular and non-cellular components, provides regulatory cues that can significantly affect c…”
BackgroundThe Extracellular Matrix: Not Just Pretty Fibrils
Hynes, R. O. (2009) · Science · doi:10.1126/science.1176009 · Cited by 3,527 · cited 1×
“The extracellular matrix (ECM) is increasingly recognized as a major player in cancer progression and metastasis, providing important regulatory cues for cellular responses.(6) Functional outcome of signaling pathways is highly context dependent and can be modulated by a particular ECM composition.”
BackgroundGenes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922 · cited 1×
“The association between high TNC levels in cancer cells and their propensity to metastasize has also been shown in breast cancer cells, where the selection for metastatic ability to colonize the lung, in a xenograft mouse model, also selects for high TNC expression.(25) How cancer cells acquire TNC expression is gener…”
BackgroundHermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., & Heeschen, C. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.06.002 · Cited by 2,897
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,406
Research works printed but not linked: 3
- 10.1002/(SICI)1097-0215(19970717)72:2%3c236::AID-IJC6%3e3.0.CO;2-S · doi:10.1002/(sici)1097-0215(19970717)72:2<236::aid-ijc6>3.0.co;2-s
- 10.1002/(SICI)1097-0215(19961220)69:6%3c445::AID-IJC4%3e3.0.CO;2-4 · doi:10.1002/(sici)1097-0215(19961220)69:6<445::aid-ijc4>3.0.co;2-4
- 10.1002/(SICI)1096-9896(199912)189:4%3c475::AID-PATH462%3e3.0.CO;2-V · doi:10.1002/(sici)1096-9896(199912)189:4<475::aid-path462>3.0.co;2-v
Cited by
Tumor microenvironment complexity and therapeutic implications at a glance
Baghban, R., Roshangar, L., Jahanban-Esfahlan, R., Seidi, K., Ebrahimi-Kalan, A., Jaymand, M., Kolahian, S., Javaheri, T., & Zare, P. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0530-4 · Cited by 1,784
“It also derive proliferation, angiogenesis and metastasis stages of tumor progression [134] .”
BackgroundIn search of definitions: Cancer‐associated fibroblasts and their markers
Nurmik, M., Ullmann, P., Rodriguez, F., Haan, S., & Letellier, E. (2020) · International Journal of Cancer · doi:10.1002/ijc.32193 · Cited by 739
Zhang, H., Yue, X., Chen, Z., Liu, C., Wu, W., Zhang, N., Liu, Z., Yang, L., Jiang, Q., Cheng, Q., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01860-5 · Cited by 424
Midwood, K. S., Chiquet, M., Tucker, R. P., & Orend, G. (2016) · Journal of Cell Science · doi:10.1242/jcs.190546 · Cited by 429
Urbanski, L. M., Leclair, N., & Anczuków, O. (2018) · WIREs RNA · doi:10.1002/wrna.1476 · Cited by 389
The Functional Role of Extracellular Matrix Proteins in Cancer
Popova, N. V., & Jücker, M. (2022) · Cancers · doi:10.3390/cancers14010238 · Cited by 275
Cancer-Associated Fibroblasts: Tumorigenicity and Targeting for Cancer Therapy
Glabman, R. A., Choyke, P. L., & Sato, N. (2022) · Cancers · doi:10.3390/cancers14163906 · Cited by 254
Affimer proteins are versatile and renewable affinity reagents
Tiede, C., Bedford, R., Heseltine, S. J., Smith, G., Wijetunga, I., Ross, R., AlQallaf, D., Roberts, A. P., Balls, A., Curd, A., et al. (2017) · eLife · doi:10.7554/elife.24903 · Cited by 203
“, 2011) and poor patient outcomes (Lowy and Oskarsson, 2015).”
Mikuła-Pietrasik, J., Uruski, P., Tykarski, A., & Książek, K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2663-1 · Cited by 197
Extracellular matrix component signaling in cancer
Multhaupt, H. A. B., Leitinger, B., Gullberg, D., & Couchman, J. R. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.013 · Cited by 193
Cancer Cell–Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma
Tian, C., Öhlund, D., Rickelt, S., Lidström, T., Huang, Y., Hao, L., Zhao, R. T., Franklin, O., Bhatia, S. N., Tuveson, D. A., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2578 · Cited by 177
Integrin αvβ6: Structure, function and role in health and disease
Koivisto, L., Bi, J., Häkkinen, L., & Larjava, H. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.04.013 · Cited by 160
Stromal integrin α11 regulates PDGFRβ signaling and promotes breast cancer progression
Primac, I., Maquoi, E., Blacher, S., Heljasvaara, R., Van Deun, J., Smeland, H. Y. H., Canale, A., Louis, T., Stuhr, L., Sounni, N. E., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125890 · Cited by 147
Evolving cancer–niche interactions and therapeutic targets during bone metastasis
Satcher, R. L., & Zhang, X. H.-F. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-021-00406-5 · Cited by 147
Cancer-associated fibroblasts: how do they contribute to metastasis?
Kwa, M. Q., Herum, K. M., & Brakebusch, C. (2019) · Clinical & Experimental Metastasis · doi:10.1007/s10585-019-09959-0 · Cited by 169
Gocheva, V., Naba, A., Bhutkar, A. J., Guardia, T., Miller, K. M., Li, C. M.-C., Dayton, T. L., Rivera, F. J. S., Kim-Kiselak, C., Jailkhani, N., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707054114 · Cited by 144
Steitz, A. M., Steffes, A., Finkernagel, F., Unger, A., Sommerfeld, L., Jansen, J. M., Wagner, U. A. G., Graumann, J., Müller, R., & Reinartz, S. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2438-8 · Cited by 155
Hongu, T., Pein, M., Insua-Rodríguez, J., Gutjahr, E., Mattavelli, G., Meier, J., Decker, K., Descot, A., Bozza, M., Harbottle, R., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00353-6 · Cited by 118
Nanomedicine-based drug delivery towards tumor biological and immunological microenvironment
Li, J., & Burgess, D. J. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.05.008 · Cited by 123
ECM deposition is driven by caveolin-1–dependent regulation of exosomal biogenesis and cargo sorting
Albacete-Albacete, L., Navarro-Lérida, I., López, J. A., Martín-Padura, I., Astudillo, A. M., Ferrarini, A., Van-Der-Heyden, M., Balsinde, J., Orend, G., Vázquez, J., et al. (2020) · Journal of Cell Biology · doi:10.1083/jcb.202006178 · Cited by 114
MMP9 modulates the metastatic cascade and immune landscape for breast cancer anti-metastatic therapy
Owyong, M., Chou, J., van den Bijgaart, R. J. E., Kong, N., Efe, G., Maynard, C., Talmi-Frank, D., Solomonov, I., Koopman, C. D., Hadler‐Olsen, E., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201800226 · Cited by 116
Therapy Resistance, Cancer Stem Cells and ECM in Cancer: The Matrix Reloaded
Kesh, K., Gupta, V. K., Durden, B. C., Garrido, V. T., Mateo-Victoriano, B., Lavania, S., & Banerjee, S. (2020) · Cancers · doi:10.3390/cancers12103067 · Cited by 121
Stella, G. M., Kolling, S., Benvenuti, S., & Bortolotto, C. (2019) · Cancers · doi:10.3390/cancers11071010 · Cited by 115
The Role of the Tumor Microenvironment and Treatment Strategies in Colorectal Cancer
Chen, Y., Zheng, X., & Wu, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.792691 · Cited by 117
Cholangiocarcinoma 2026: status quo, unmet needs and priorities
Bañales, J. M., Rodrigues, P. M., Affò, S., Andersen, J. B., Aspichueta, P., Boulter, L., Bridgewater, J. A., Calvisi, D. F., Cárdenas, A., Cardinale, V., et al. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01153-w · Cited by 138
The Role of Extracellular Matrix Proteins in Breast Cancer
Lepucki, A., Orlińska, K., Mielczarek‐Palacz, A., Kabut, J., Olczyk, P., & Komosińska‐Vassev, K. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11051250 · Cited by 114
Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity
Marzeda, A. M., & Midwood, K. S. (2018) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155418757443 · Cited by 95
Pedersen, E. A., Menon, R., Bailey, K. M., Thomas, D. G., Noord, R. A. V., Tran, J. N., Wang, H., Qü, P., Hoering, A., Fearon, E. R., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3422 · Cited by 108
Danieau, G., Morice, S., Rédiní, F., Verrecchia, F., & Royer, B. B.-L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153751 · Cited by 93
Li, C.-Q., Huang, G.-W., Wu, Z.-Y., Xu, Y.-J., Li, X.-C., Xue, Y.-J., Zhu, Y., Zhao, J.-M., Li, M., Zhang, J., et al. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.1 · Cited by 79
Koshizuka, K., Nohata, N., Hanazawa, T., Kikkawa, N., Arai, T., Okato, A., Fukumoto, I., Katada, K., Okamoto, Y., & Seki, N. (2017) · Oncotarget · doi:10.18632/oncotarget.16327 · Cited by 72
Pathogenesis of peri-tumoral edema in intracranial meningiomas
Berhouma, M., Jacquesson, T., Jouanneau, E., & Cotton, F. (2017) · Neurosurgical Review · doi:10.1007/s10143-017-0897-x · Cited by 78
Remodeling the ECM: Implications for Metastasis and Tumor Dormancy
Martino, J. S. D., Akhter, T., & Bravo‐Cordero, J. J. (2021) · Cancers · doi:10.3390/cancers13194916 · Cited by 76
Markers of Cancer Cell Invasion: Are They Good Enough?
Gerashchenko, T. S., Novikov, N. M., Krakhmal, N. V., Zolotareva, S. Y., Zavyalova, M. V., Чердынцева, Н. В., Denisov, E. V., & Михайлович, П. В. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081092 · Cited by 74
Advances on the roles of tenascin-C in cancer
Yilmaz, A., Loustau, T., Salomé, N., Surendran, S. P., Li, C., Tucker, R. P., Izzi, V., Lamba, R., Koch, M., & Orend, G. (2022) · Journal of Cell Science · doi:10.1242/jcs.260244 · Cited by 67
Davodabadi, F., Mirinejad, S., Fathi‐karkan, S., Majidpour, M., Ajalli, N., Sheervalilou, R., Sargazi, S., Rozmus, D., Rahdar, A., & Diez-Pascual, A. M. (2023) · Biotechnology Progress · doi:10.1002/btpr.3366 · Cited by 63
Elie, B. T., Fernández‐Gallardo, J., Curado, N., Cornejo, M., Ramos, J. W., & Contel, M. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.10.034 · Cited by 59
Murakami, T., Kikuchi, H., Ishimatsu, H., Iino, I., Hirotsu, A., Matsumoto, T., Ozaki, Y., Kawabata, T., Hiramatsu, Y., Ohta, M., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.291 · Cited by 60
Sirica, A. E., Strazzabosco, M., & Cadamuro, M. (2020) · Advances in cancer research · doi:10.1016/bs.acr.2020.10.005 · Cited by 62
Loss of Tenascin-X expression during tumor progression: A new pan-cancer marker
Liot, S., Aubert, A., Hervieu, V., Kholti, N. E., Schalkwijk, J., Verrier, B., Valcourt, U., & Lambert, E. (2020) · Matrix Biology Plus · doi:10.1016/j.mbplus.2020.100021 · Cited by 63
Caveolae Mechanotransduction at the Interface between Cytoskeleton and Extracellular Matrix
Sotodosos-Alonso, L., Pulgarín-Alfaro, M., & del Pozo, M. Á. (2023) · Cells · doi:10.3390/cells12060942 · Cited by 59
Mechanical Forces as Determinants of Disseminated Metastatic Cell Fate
Montagner, M., & Dupont, S. (2020) · Cells · doi:10.3390/cells9010250 · Cited by 56
Tenascin C promotes cancer cell plasticity in mesenchymal glioblastoma
Angel, I., Kerman, O. P., Rousso-Noori, L., & Friedmann‐Morvinski, D. (2020) · Oncogene · doi:10.1038/s41388-020-01506-6 · Cited by 52
Prados, M. E., García‐Martín, A., Unciti-Broceta, J. D., Palomares, B., Collado, J. A., Minassi, A., Calzado, M. A., Appendino, G., & Muñóz, E. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0497-0 · Cited by 50
Latent TGF-β Activation Is a Hallmark of the Tenascin Family
Aubert, A., Mercier‐Gouy, P., Aguero, S., Berthier, L., Liot, S., Prigent, L., Alcaraz, L. B., Verrier, B., Terreux, R., Moali, C., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.613438 · Cited by 47
Dong, R., Guo, J., Zhang, Z., Zhou, Y., & Hua, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.193 · Cited by 43
Derakhshani, A., Rostami, Z., Safarpour, H., Shadbad, M. A., Nourbakhsh, N. S., Argentiero, A., Taefehshokr, S., Tabrizi, N. J., Kooshkaki, O., Astamal, R. V., et al. (2021) · Molecules · doi:10.3390/molecules26082278 · Cited by 46
Albacete-Albacete, L., Sánchez‐Álvarez, M., & del Pozo, M. Á. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.671485 · Cited by 47
Harman, R. M., He, M. K., Zhang, S., & de Walle, G. R. V. (2018) · Cytotherapy · doi:10.1016/j.jcyt.2018.06.005 · Cited by 43
Geleta, B., Shehadeh-Tout, F., Lim, S. C., Sahni, S., Jansson, P. J., Apte, M. V., Richardson, D. R., & Kovačević, Ž. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101608 · Cited by 40
Fibroblast subtypes define a metastatic matrisome in breast cancer
Brechbuhl, H. M., Barrett, A. S., Kopin, E. G., Hagen, J., Han, A., Gillen, A. E., Finlay-Schultz, J., Cittelly, D. M., Owens, P., Horwitz, K. B., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.130751 · Cited by 40
Yonemura, A., Semba, T., Zhang, J., Fan, Y., Yasuda‐Yoshihara, N., Wang, H., Uchihara, T., Yasuda, T., Nishimura, A., Fu, L., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2023.113613 · Cited by 42
Tenascin-C expression in the lymph node pre-metastatic niche in muscle-invasive bladder cancer
Silvers, C. R., Messing, E. M., Miyamoto, H., & Lee, Y. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01554-z · Cited by 32
Matricellular Proteins: Functional Insights From Non-mammalian Animal Models
Adams, J. C. (2018) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2018.02.003 · Cited by 34
Revisiting the Tenascins: Exploitable as Cancer Targets?
Tucker, R. P., & Degen, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.908247 · Cited by 37
Liver Matrix in Benign and Malignant Biliary Tract Disease
Fabris, L., Cadamuro, M., Cagnin, S., Strazzabosco, M., & Gores, G. J. (2020) · Seminars in Liver Disease · doi:10.1055/s-0040-1705109 · Cited by 31
Immune Remodeling of the Extracellular Matrix Drives Loss of Cancer Stem Cells and Tumor Rejection
Pires, A., Greenshields‐Watson, A., Jones, E., Smart, K., Lauder, S. N., Somerville, M. S., Milutinovic, S., Kendrick, H. D., Hindley, J. P., French, R., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0070 · Cited by 33
Obesity alters the ovarian proteomic response to zearalenone exposure
González-Alvarez, M. E., McGuire, B. C., & Keating, A. F. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab069 · Cited by 31
Biology of Tenascin C and its Role in Physiology and Pathology
Abedsaeidi, M., Hojjati, F., Tavassoli, A., & Sahebkar, A. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230404124229 · Cited by 29
Tenascin-C targeting strategies in cancer
Dhaouadi, S., Bouhaouala‐Zahar, B., & Orend, G. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.04.002 · Cited by 31
Yoneura, N., Takano, S., Yoshitomi, H., Nakata, Y., Shimazaki, R., Kagawa, S., Furukawa, K., Takayashiki, T., Kuboki, S., Miyazaki, M., et al. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3652 · Cited by 36
IL-33/ST2 axis promotes glioblastoma cell invasion by accumulating tenascin-C
Zhang, J.-F., Tao, T., Wang, K., Zhang, G.-X., Yan, Y., Lin, H.-R., Li, Y., Guan, M.-W., Yu, J.-J., & Wang, X.-D. (2019) · Scientific Reports · doi:10.1038/s41598-019-56696-1 · Cited by 25
Kindlin-1 Promotes Pulmonary Breast Cancer Metastasis
Sarvi, S., Patel, H., Li, J., Dodd, G. L., Creedon, H., Muir, M., Ward, J. L., Dawson, J. C., Lee, M. W., Culley, J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1518 · Cited by 35
Yang, J.-L., Wang, C. C. N., Cai, J.-H., Chou, C., Lin, Y., & Hung, C. (2020) · Cancers · doi:10.3390/cancers12071809 · Cited by 27
Akanda, M. R., Ahn, E., Kim, Y. J., Salam, S. M. A., Noh, M., Kim, S. S., Jung, T., Kim, I., Kim, C., Lee, K., et al. (2023) · Journal of Cancer · doi:10.7150/jca.80115 · Cited by 29
Strategic outline of interventions targeting extracellular matrix for promoting healthy longevity
Park, J. Y. C., King, A., Björk, V., English, B. W., Fedintsev, A., & Ewald, C. Y. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00060.2023 · Cited by 33
Nayak, C., & Singh, S. K. (2022) · ACS Omega · doi:10.1021/acsomega.2c01820 · Cited by 27
Coleman, D. T., Gray, A. L., Stephens, C. A., Scott, M. L., & Cardelli, J. A. (2016) · Oncotarget · doi:10.18632/oncotarget.8609 · Cited by 29
Novel Human Tenascin-C Function-Blocking Camel Single Domain Nanobodies
Dhaouadi, S., Abderrazek, R. B., Loustau, T., Fayçal, C. A., Ksouri, A., Erne, W., Murdamoothoo, D., Mörgelin, M., Kungl, A. J., Jung, A. C., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.635166 · Cited by 23
Jailkhani, N., Clauser, K. R., Mak, H. H., Rickelt, S., Tian, C., Whittaker, C. A., Tanabe, K. K., Purdy, S. R., Carr, S. A., & Hynes, R. O. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-1532 · Cited by 22
Cerebrospinal Fluid Concentrations of Extracellular Matrix Proteins in Alzheimer’s Disease
Minta, K., Portelius, E., Janelidze, S., Hansson, O., Zetterberg, H., Blennow, K., & Andréasson, U. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190187 · Cited by 25
Hawkins, A. G., Julian, C. M., Konzen, S. M., Treichel, S., Lawlor, E. R., & Bailey, K. M. (2019) · Neoplasia · doi:10.1016/j.neo.2019.08.007 · Cited by 21
Forsyth, R. G., Krenács, T., Athanasou, N. A., & Hogendoorn, P. C. W. (2021) · Cancers · doi:10.3390/cancers13205119 · Cited by 25
Matricellular proteins as regulators of cancer metastasis to bone
Trotter, T. N., & Yang, Y. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.01.006 · Cited by 25
Horizontal Transfer of Malignant Traits and the Involvement of Extracellular Vesicles in Metastasis
Arena, G. O., Forte, S., Abdouh, M., Vanier, C. H., Corbeil, D., & Lorico, A. (2023) · Cells · doi:10.3390/cells12121566 · Cited by 19
Karkampouna, S., Filippo, M. R. D., Ng, C. K. Y., Klima, I., Zoni, E., Spahn, M., Stein, F., Haberkant, P., Thalmann, G. N., & Julio, M. K. (2020) · Cancers · doi:10.3390/cancers12123786 · Cited by 24
The role of tenascin-C in tumor microenvironments and its potential as a therapeutic target
Wang, Y., Wen, X., Su, C., You, Y., Jiang, Z., Fan, Q., & Zhu, D. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1554312 · Cited by 18
EphB6 Regulates TFEB-Lysosomal Pathway and Survival of Disseminated Indolent Breast Cancer Cells
Zangrossi, M., Chakravarty, P., Romani, P., Ratcliffe, C. D. H., Hooper, S., Dori, M., Forcato, M., Bicciato, S., Dupont, S., Sahai, E. A., et al. (2021) · Cancers · doi:10.3390/cancers13051079 · Cited by 19
Cheng, X., Li, F., & Tao, Z. (2021) · Oncology Letters · doi:10.3892/ol.2021.12831 · Cited by 20
Exploiting ECM remodelling to promote immune-mediated tumour destruction
Pires, A., Burnell, S. E. A., & Gallimore, A. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2021.09.006 · Cited by 22
Schmidt, M., Skaf, J., Gavril, G., Polednik, C., Roller, J., Kessler, M. T., & Holzgrabe, U. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-2009-4 · Cited by 18
Spillane, C. D., Cooke, N. M., Ward, M. P., Kenny, D. J., Blackshields, G., Kelly, T. E., Bates, M., Huang, Y., Martin, C. M., Skehan, S., et al. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101229 · Cited by 17
Role of TGM2 in T‑cell lymphoblastic lymphoma via regulation of IL‑6/JAK/STAT3 signalling
Wang, Y., Zheng, N., Sun, T., Zhao, H., Chen, Y., & Liu, C. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12592 · Cited by 19
Furuhashi, S., Sakaguchi, T., Murakami, T., Fukushima, M., Morita, Y., Ikegami, K., Kikuchi, H., Setou, M., & Takeuchi, H. (2020) · Pancreas · doi:10.1097/mpa.0000000000001506 · Cited by 19
Fejza, A., Camicia, L., Poletto, E., Carobolante, G., Mongiat, M., & Andreuzzi, E. (2021) · Cancers · doi:10.3390/cancers13112759 · Cited by 18
Extracellular Vesicles: Biological Packages That Modulate Tumor Cell Invasion
Schmidtmann, M., & D’Souza‐Schorey, C. (2023) · Cancers · doi:10.3390/cancers15235617 · Cited by 17
Zhang, Q., Lou, Y., Fang, H., Sun, S., Jin, R., Ji, Y., & Chen, Z. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12438 · Cited by 21
Liu, S., Wang, Z., Zhu, D., Yang, J., Lou, D., Gao, R., Wang, Z., Li, A., Lv, Y., & Fan, Q. (2020) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2020.11.010 · Cited by 15
Gomig, T. H. B., Cavalli, I. J., de Souza, R. L. R., Vieira, E., Lucena, A. C. R., Batista, M., Machado, K. C., Marchini, F. K., Marchi, F. A., de Lima, R. S., et al. (2019) · Journal of Proteomics · doi:10.1016/j.jprot.2019.02.007 · Cited by 15
Immunotherapy: breaching the barriers for cancer treatment
Martínez, V. G., Park, D., & Acton, S. E. (2019) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2018.0214 · Cited by 15
Luan, S., Yang, Y., Zhou, Y., Zeng, X., Xiao, X. H., Liu, B., & Yuan, Y. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03751-0 · Cited by 14
Matricellular proteins in intrahepatic cholangiocarcinoma
Sirica, A. E. (2022) · Advances in cancer research · doi:10.1016/bs.acr.2022.01.010 · Cited by 15
Tenascin XB Is a Novel Diagnostic Marker for Malignant Mesothelioma
NAKAYAMA, K., Seike, M., Noro, R., Takeuchi, S., Matsuda, K., Kunugi, S., Kubota, K., & Gemma, A. (2019) · Anticancer Research · doi:10.21873/anticanres.13156 · Cited by 17
Jézéquel, P., Guette, C., Lasla, H., Gouraud, W., Boissard, A., Guérin‐Charbonnel, C., & Campone, M. (2019) · PROTEOMICS · doi:10.1002/pmic.201800484 · Cited by 16
Histone H3K9 methyltransferase SETDB1 augments invadopodia formation to promote tumor metastasis
Ueshima, S., & Fang, J. (2022) · Oncogene · doi:10.1038/s41388-022-02345-3 · Cited by 17
Prognostic Role of Tenascin-C for Cancer Outcome: A Meta-Analysis
Ming, X., Qiu, S., Liu, X., Li, S., Wang, Y., Zhu, M., Li, N., Luo, P., Liang, C., & Tu, J. (2019) · Technology in Cancer Research & Treatment · doi:10.1177/1533033818821106 · Cited by 16
Modulating tenascin-C functions by targeting the MAtrix REgulating MOtif, “MAREMO”
Loustau, T., Fayçal, C. A., Erne, W., Wiesch, P. A. Z., Ksouri, A., Imhof, T., Mörgelin, M., Li, C., Mathieu, M., Salomé, N., et al. (2022) · Matrix Biology · doi:10.1016/j.matbio.2022.02.007 · Cited by 13
Jimenez, L., Stolzenbach, V., Ozawa, P. M. M., Ramirez-Solano, M. A., Liu, Q., Sage, J., & Weaver, A. M. (2023) · PROTEOMICS · doi:10.1002/pmic.202300030 · Cited by 14
Did Tenascin-C Co-Evolve With the General Immune System of Vertebrates?
Orend, G., & Tucker, R. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.663902 · Cited by 13
Schuler, L. A., & Murdoch, F. E. (2021) · Cancers · doi:10.3390/cancers13153725 · Cited by 14
Metadata
- Authors
- Lowy, C. M., & Oskarsson, T.
- Affiliations
- German Cancer Research Center (DE)
- Venue
- Cell Adhesion & Migration
- Publisher
- Informa UK Limited
- Published
- 2015-01-02
- Volume
- 9
- Issue
- 1-2
- Pages
- 112-124
- ISSN
- 1933-6918 (ISSN-L)
- 1933-6926
- PMC
- PMC4422797
- OpenAlex
- W1868626511
- Cited by
- 178
- References
- 166
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 10 · 2023: 16 · 2022: 25 · 2021: 26 · 2020: 27 · 2019: 21 · 2018: 14 · 2017: 13 · 2016: 7 · 2015: 2
- FWCI
- 5.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Cell Adhesion & Migration (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- tenascin-C, metastasis, extracellular matrix, tumor invasion, tumor cell migration, angiogenesis, metastatic niche, cancer stem cells, stem cell signaling, cancer cell fitness, poor prognosis
- MeSH terms
- Animals, Cell Adhesion, Cell Movement, Extracellular Matrix, Humans, Neoplasm Metastasis, Neoplasms, Tenascin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.